Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial.

Saved in:
Bibliographic Details
Title: Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial.
Authors: Samuels AM; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, United States Centers for Disease Control and Prevention, Kisumu, Kenya; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: amsamuels@cdc.gov., Ansong D; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Kariuki SK; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Adjei S; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Bollaerts A; GSK, Wavre, Belgium., Ockenhouse C; PATH's Malaria Vaccine Initiative, Washington, DC, USA., Westercamp N; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA., Lee CK; PATH's Malaria Vaccine Initiative, Washington, DC, USA., Schuerman L; GSK, Wavre, Belgium., Bii DK; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Osei-Tutu L; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Oneko M; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Lievens M; GSK, Wavre, Belgium., Attobrah Sarfo MA; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Atieno C; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Morelle D; GSK, Wavre, Belgium., Bakari A; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Sang T; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Jongert E; GSK, Wavre, Belgium., Kotoh-Mortty MF; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Otieno K; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Roman F; GSK, Wavre, Belgium., Buabeng PBY; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Ntiamoah Y; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana., Ofori-Anyinam O; GSK, Wavre, Belgium., Agbenyega T; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
Corporate Authors: RTS,S study group
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Sep; Vol. 22 (9), pp. 1329-1342. Date of Electronic Publication: 2022 Jun 23.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35753316
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of RTS,S/AS01<subscript>E</subscript> malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Samuels+AM%22">Samuels AM</searchLink>; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, United States Centers for Disease Control and Prevention, Kisumu, Kenya; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: amsamuels@cdc.gov.<br /><searchLink fieldCode="AU" term="%22Ansong+D%22">Ansong D</searchLink>; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.<br /><searchLink fieldCode="AU" term="%22Kariuki+SK%22">Kariuki SK</searchLink>; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.<br /><searchLink fieldCode="AU" term="%22Adjei+S%22">Adjei S</searchLink>; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.<br /><searchLink fieldCode="AU" term="%22Bollaerts+A%22">Bollaerts A</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Ockenhouse+C%22">Ockenhouse C</searchLink>; PATH's Malaria Vaccine Initiative, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Westercamp+N%22">Westercamp N</searchLink>; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+CK%22">Lee CK</searchLink>; PATH's Malaria Vaccine Initiative, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Schuerman+L%22">Schuerman L</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Bii+DK%22">Bii DK</searchLink>; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.<br /><searchLink fieldCode="AU" term="%22Osei-Tutu+L%22">Osei-Tutu L</searchLink>; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.<br /><searchLink fieldCode="AU" term="%22Oneko+M%22">Oneko M</searchLink>; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.<br /><searchLink fieldCode="AU" term="%22Lievens+M%22">Lievens M</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Attobrah+Sarfo+MA%22">Attobrah Sarfo MA</searchLink>; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.<br /><searchLink fieldCode="AU" term="%22Atieno+C%22">Atieno C</searchLink>; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.<br /><searchLink fieldCode="AU" term="%22Morelle+D%22">Morelle D</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Bakari+A%22">Bakari A</searchLink>; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.<br /><searchLink fieldCode="AU" term="%22Sang+T%22">Sang T</searchLink>; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.<br /><searchLink fieldCode="AU" term="%22Jongert+E%22">Jongert E</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Kotoh-Mortty+MF%22">Kotoh-Mortty MF</searchLink>; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.<br /><searchLink fieldCode="AU" term="%22Otieno+K%22">Otieno K</searchLink>; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.<br /><searchLink fieldCode="AU" term="%22Roman+F%22">Roman F</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Buabeng+PBY%22">Buabeng PBY</searchLink>; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.<br /><searchLink fieldCode="AU" term="%22Ntiamoah+Y%22">Ntiamoah Y</searchLink>; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.<br /><searchLink fieldCode="AU" term="%22Ofori-Anyinam+O%22">Ofori-Anyinam O</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Agbenyega+T%22">Agbenyega T</searchLink>; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22RTS%2CS+study+group%22">RTS,S study group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2022 Sep; Vol. 22 (9), pp. 1329-1342. <i>Date of Electronic Publication: </i>2022 Jun 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35753316
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1473-3099(22)00273-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1329
    Titles:
      – TitleFull: Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Samuels AM
      – PersonEntity:
          Name:
            NameFull: Ansong D
      – PersonEntity:
          Name:
            NameFull: Kariuki SK
      – PersonEntity:
          Name:
            NameFull: Adjei S
      – PersonEntity:
          Name:
            NameFull: Bollaerts A
      – PersonEntity:
          Name:
            NameFull: Ockenhouse C
      – PersonEntity:
          Name:
            NameFull: Westercamp N
      – PersonEntity:
          Name:
            NameFull: Lee CK
      – PersonEntity:
          Name:
            NameFull: Schuerman L
      – PersonEntity:
          Name:
            NameFull: Bii DK
      – PersonEntity:
          Name:
            NameFull: Osei-Tutu L
      – PersonEntity:
          Name:
            NameFull: Oneko M
      – PersonEntity:
          Name:
            NameFull: Lievens M
      – PersonEntity:
          Name:
            NameFull: Attobrah Sarfo MA
      – PersonEntity:
          Name:
            NameFull: Atieno C
      – PersonEntity:
          Name:
            NameFull: Morelle D
      – PersonEntity:
          Name:
            NameFull: Bakari A
      – PersonEntity:
          Name:
            NameFull: Sang T
      – PersonEntity:
          Name:
            NameFull: Jongert E
      – PersonEntity:
          Name:
            NameFull: Kotoh-Mortty MF
      – PersonEntity:
          Name:
            NameFull: Otieno K
      – PersonEntity:
          Name:
            NameFull: Roman F
      – PersonEntity:
          Name:
            NameFull: Buabeng PBY
      – PersonEntity:
          Name:
            NameFull: Ntiamoah Y
      – PersonEntity:
          Name:
            NameFull: Ofori-Anyinam O
      – PersonEntity:
          Name:
            NameFull: Agbenyega T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2022 Sep
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1474-4457
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: The Lancet. Infectious diseases
              Type: main
ResultId 1